Published Online : 2024-06-30
Background: Stroke is among the most common causes of adult-onset disability. 70–85% of first strokes are accompanied by hemiplegia. Several case control studies with ischemic stroke patients have indicated that recent infections are a possible risk factor for ischemic stroke. Stroke occurs when reduced blood supply to the brain results in cell death. Aim: The aim of this study is to compare serum high sensitive C-reactive protein levels in stroke patients to controls. Objective: The primary goal of this study is to examine serum high sensitive C-reactive protein levels in stroke patients and to link them to stroke related death. The secondary goal is to enhance AMI early detection, management and therapy, and prognosis. Material & Methods: The present study was carried out in the Department of physiotherapy and Central Investigation Laboratory in collaboration with the Department of Biochemistry Medicine, Intense cardiac care units, medical intensive care units, and emergency and private hospitals. The study was approved by Institutional Ethical and Research Committee to use human subjects in the research study. Informed consent was taken from patient and control subjects. Out of 100 subjects, 50 were strokes patients and 50 were age matched healthy controls. The study was conducted from June 2023 to March 2024. The Microlab 300 analyzers (semiauto analyzer) were used to assess High Sensitive C-reactive Protein concentrations, and the comparisons between the two groups were examined using an unpaired t-test. A P < 0.05 was deemed statistically significant. Results: There was a substantial elevated in the mean serum high sensitive C-reactive protein in strokes cases were 5.86 ± 3.12 mg/dl, which were higher than controls group 2.41 ± 1.27 mg/ dl. Comparison between control and serum high sensitive C-reactive protein on strokes cases was found to be more significant. Unpaired t-test showed that there was significant increase in serum high sensitive C-reactive protein level in cases as compared to controls (p<0.005). Conclusion: The analysis of serum high sensitive C-reactive protein in serum plays an important role in the diagnostic marker and management of ischemic strokes.
Original Article
English
P. 69-73